-
公开(公告)号：US09597440B2
公开(公告)日：2017-03-21
申请号：US14613725
申请日：2015-02-04
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M37/00 , C02F1/44 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.
-
公开(公告)号：US20150367054A1
公开(公告)日：2015-12-24
申请号：US14828990
申请日：2015-08-18
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
CPC classification number: A61M1/1601 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号：US20150352269A1
公开(公告)日：2015-12-10
申请号：US14828979
申请日：2015-08-18
Applicant: MEDTRONIC, INC.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16
CPC classification number: A61M1/1601 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
Abstract translation: 方法包括监测血液流体清除过程中血液pH值或血液电解质水平的指标，并根据监测的指标调整会话期间使用的透析液或替代液体中pH缓冲液或电解质的浓度。 血液清除系统可以使用监测血液pH值或电解质水平的传感器，以在血液清除期间调整流体参数。
-
公开(公告)号：US20150080682A1
公开(公告)日：2015-03-19
申请号：US14554338
申请日：2014-11-26
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
Abstract translation: 一种方法包括通过传感器装置监测患者的流体体积的指示器，以及基于所监视的流体体积的指示器设定用于血液流体清除会话的初始流体体积去除处方。 该方法还可以包括将关于流体体积指示器的数据从可植入传感器装置传送到流体移除装置。 该系统包括血液流体清除装置和配置成设置初始流体去除体积和速率处方的控制电子装置。 在一些实施例中，流体移除装置基于从可植入传感器接收的数据设置或计算初始流体体积去除处方。 流体体积的指标可以是组织液体体积的指标或血液体积的指标。
-
公开(公告)号：US20130197562A1
公开(公告)日：2013-08-01
申请号：US13749391
申请日：2013-01-24
Applicant: Medtronic, Inc.
Inventor： John Burnes , Warren Starkebaum
IPC: A61F5/00
CPC classification number: A61F5/003 , A61F5/0013
Abstract: Medical devices, systems and methods are provided and are designed to stretch the stomach wall of a patient to treat obesity. Stretch devices attached to the stomach wall may trigger stretch receptors to expand the stomach into a state of apparent stretching, causing early onset of satiety thereby causing the patient to consume less food. Stretching of the stomach can be achieved by the attachment of stretch devices to the wall of the stomach. The devices may be expandable and contractible and, in some embodiments, may take the form of a device that expands following attachment to a wall of the stomach.
Abstract translation: 提供了医疗装置，系统和方法，并被设计成拉伸患者的胃壁以治疗肥胖。 附着在胃壁上的拉伸装置可以触发拉伸受体以将胃膨胀成明显的拉伸状态，导致早期的饱腹感，从而导致患者消耗更少的食物。 可以通过将拉伸装置附接到胃壁来实现胃的伸展。 所述装置可以是可扩张的和可收缩的，并且在一些实施例中，可以采取在附着于胃壁之后扩张的装置的形式。
-
Patent Agency Ranking
公开(公告)号：US11759557B2
公开(公告)日：2023-09-19
申请号：US17034250
申请日：2020-09-28
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , Venkatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/00 , A61M1/00 , A61B5/053 , G16H20/17 , G16H40/63 , A61B5/145 , A61M1/34 , A61M1/36 , A61M1/14 , B01D61/00 , B01D61/32 , A61B5/0295 , A61B5/0537 , B01D65/02 , G16Z99/00 , G16H20/40 , A61B5/026 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/6866 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/342 , A61M1/3403 , A61M1/361 , A61M1/3607 , A61M1/3609 , A61M1/3612 , B01D61/00 , B01D61/32 , B01D65/02 , G16H20/17 , G16H20/40 , G16H40/63 , G16Z99/00 , A61B2560/0223 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D2321/12 , B01D2321/40
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US10967112B2
公开(公告)日：2021-04-06
申请号：US15693535
申请日：2017-09-01
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/145 , A61B5/00 , A61M1/34 , A61M1/36 , A61M1/00 , A61M1/14 , A61B5/0295 , A61B5/053 , A61B5/026 , A61M1/28 , B01D61/00 , B01D61/32 , B01D65/02 , A61B5/0537 , G06F19/00
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US20210008265A1
公开(公告)日：2021-01-14
申请号：US17034250
申请日：2020-09-28
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61B5/145 , A61B5/00 , A61M1/34 , A61M1/36 , A61M1/00 , A61M1/14 , B01D61/00 , B01D61/32 , A61B5/0295 , A61B5/053 , B01D65/02 , A61B5/026 , A61M1/28
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US20200289056A1
公开(公告)日：2020-09-17
申请号：US16805054
申请日：2020-02-28
Applicant: Medtronic, Inc.
Inventor： John Burnes , VenKatesh Manda , Tico Blumenthal , Orhan Soykan
IPC: A61B5/00 , A61B5/0205 , A61B5/021 , A61B5/145 , A61B5/0452 , G16H50/30 , G16H20/17 , G16H20/40 , G16H40/67
Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.
-
公开(公告)号：US10335534B2
公开(公告)日：2019-07-02
申请号：US15333267
申请日：2016-10-25
Applicant: Medtronic, Inc.
Inventor： Amy Roettger , VenKatesh R. Manda , John Burnes , Rebecca Poindexter , Martin T. Gerber
Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.02 seconds)
